A Phase 1, Open-Label, Single-Dose Study to Assess the Mass Balance, Pharmacokinetics and Metabolism of Intravenously Administered 14C-AAI101 in Healthy Male Subjects
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Enmetazobactam (Primary)
- Indications Gram-negative infections
- Focus Pharmacokinetics
- Sponsors Allecra Therapeutics
Most Recent Events
- 25 Feb 2019 Status changed from recruiting to completed.
- 21 Dec 2018 New trial record